126 results on '"Sharma, Satya Priya"'
Search Results
2. Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway
3. The identification of metabolites from gut microbiota in NAFLD via network pharmacology
4. The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
5. Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment
6. Gut microbiome and metabolome signatures in liver cirrhosis-related complications.
7. Microbial influence on liver regeneration: understanding gut microbiota and hepatic recovery post partial hepatectomy
8. Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
9. New insight of chemical constituents in Persea americana fruit against obesity via integrated pharmacology.
10. Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease
11. Clinicopathological and prognostic significance of GPC3 in human breast cancer and its 3D structure prediction
12. Potential gut microbial biomarkers for detection of sarcopenia in alcohol-related liver disease patients
13. Identification of complication- dependent gut microbial biomarkers for early detection of decompensated cirrhosis
14. Increased concentration of 4-hydroxyphenyllactic acid in patients with alcohol-related liver disease could promote the growth of Lactobacillus spp
15. Pasteurized Akkermansia muciniphila inhibits fibrosis progression in mouse cirrhosis model and induces changes in the gut microbiome
16. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease
17. Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation.
18. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis.
19. New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study.
20. New insight of chemical constituents in Persea americana fruit against obesity via data-driven analysis
21. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis
22. The orchestration of Cornus kousa fruit and gut microbiota for anti- obesity via integrated pharmacological analysis based on metabolomics
23. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease
24. Ultra-High Efficient Colony PCR for High Throughput Screening of Bacterial Genes
25. The combined application of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via network pharmacology approach
26. Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
27. Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
28. A network pharmacology study to determine the integrated application of dietary plant-derived natural flavonoids and gut microbiota against nonalcoholic fatty liver disease
29. The Link between Gut Microbiota and Hepatic Encephalopathy
30. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
31. Exploration of metabolites from gut microbiota against nonalcoholic fatty liver disease: A network pharmacology-based study
32. Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
33. Plasma and urinary extracellular vesicle microRNAs and their related pathways in diabetic kidney disease
34. Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
35. The Lactobacillus as a Probiotic: Focusing on Liver Diseases
36. T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
37. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
38. Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
39. The resveratrol-enriched rice DJ526 boosts motor coordination and physical strength
40. THU-227 - Pasteurized Akkermansia muciniphila inhibits fibrosis progression in mouse cirrhosis model and induces changes in the gut microbiome
41. THU-354 - Identification of complication- dependent gut microbial biomarkers for early detection of decompensated cirrhosis
42. FRI-456 - Potential gut microbial biomarkers for detection of sarcopenia in alcohol-related liver disease patients
43. FRI-420 - Increased concentration of 4-hydroxyphenyllactic acid in patients with alcohol-related liver disease could promote the growth of Lactobacillus spp
44. Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis
45. Arsenic Remediation in Bangladeshi Rice Varieties with Enhance Plant Growth by Unique Arsenic-Resistant Bacterial Isolates
46. Arsenic Remediation in Bangladeshi Rice Varieties with Enhance Plant Growth by Unique Arsenic-Resistant Bacterial Isolates.
47. Antibacterial Properties and Chemical Composition of Essential Oil fromAegle marmelos(L.) Corr. Leaves Growing in Bangladesh
48. Antibacterial Properties and Chemical Composition of Essential Oil from Aegle marmelos (L.) Corr. Leaves Growing in Bangladesh.
49. Rapid Identification of Yeast Isolates from Clinical Specimens in Critically Ill Trauma ICU Patients
50. Antibacterial Properties and Chemical Composition of Essential Oil from Aegle marmelos(L.) Corr. Leaves Growing in Bangladesh
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.